These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 14607077)

  • 21. Bio-markers of disease activity and response to therapy in multiple sclerosis.
    Miller A; Glass-Marmor L; Abraham M; Grossman I; Shapiro S; Galboiz Y
    Clin Neurol Neurosurg; 2004 Jun; 106(3):249-54. PubMed ID: 15177778
    [No Abstract]   [Full Text] [Related]  

  • 22. Astaxanthin: a novel potential treatment for oxidative stress and inflammation in cardiovascular disease.
    Pashkow FJ; Watumull DG; Campbell CL
    Am J Cardiol; 2008 May; 101(10A):58D-68D. PubMed ID: 18474276
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.
    Calabrese V; Lodi R; Tonon C; D'Agata V; Sapienza M; Scapagnini G; Mangiameli A; Pennisi G; Stella AM; Butterfield DA
    J Neurol Sci; 2005 Jun; 233(1-2):145-62. PubMed ID: 15896810
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oxidative stress detection: what for? Part II.
    Palmieri B; Sblendorio V
    Eur Rev Med Pharmacol Sci; 2007; 11(1):27-54. PubMed ID: 17405347
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum and cerebrospinal fluid uric acid levels in multiple sclerosis patients.
    Zamani A; Rezaei A; Khaeir F; Hooper DC
    Clin Neurol Neurosurg; 2008 Jun; 110(6):642-3. PubMed ID: 18471958
    [No Abstract]   [Full Text] [Related]  

  • 26. Salivary uric acid at the acidic pH of the stomach is the principal defense against nitrite-derived reactive species: sparing effects of chlorogenic acid and serum albumin.
    Pietraforte D; Castelli M; Metere A; Scorza G; Samoggia P; Menditto A; Minetti M
    Free Radic Biol Med; 2006 Dec; 41(12):1753-63. PubMed ID: 17157178
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The influence of uric acid treatments on liver glutathione system prevent oxidative damages in experimental autoimmune encephalomyelitis mice.
    Allameh A; Maleklou N; Zargari M; Sanati MH
    Neurosci Lett; 2008 Jul; 439(1):111-5. PubMed ID: 18501514
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sickle cell disease: role of reactive oxygen and nitrogen metabolites.
    Wood KC; Granger DN
    Clin Exp Pharmacol Physiol; 2007 Sep; 34(9):926-32. PubMed ID: 17645642
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multi-target-directed ligands to combat neurodegenerative diseases.
    Cavalli A; Bolognesi ML; Minarini A; Rosini M; Tumiatti V; Recanatini M; Melchiorre C
    J Med Chem; 2008 Feb; 51(3):347-72. PubMed ID: 18181565
    [No Abstract]   [Full Text] [Related]  

  • 30. Role of Nrf2 signaling in regulation of antioxidants and phase 2 enzymes in cardiac fibroblasts: protection against reactive oxygen and nitrogen species-induced cell injury.
    Zhu H; Itoh K; Yamamoto M; Zweier JL; Li Y
    FEBS Lett; 2005 Jun; 579(14):3029-36. PubMed ID: 15896789
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Reactive oxygen and nitrogen species in the clinical medicine].
    Macásek J; Zeman M; Vecka M; Vávrová L; Kodydková J; Tvrzická E; Zák A
    Cas Lek Cesk; 2011; 150(8):423-32. PubMed ID: 22026076
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The two faces of L-DOPA: benefits and adverse side effects in the treatment of Encephalitis lethargica, Parkinson's disease, multiple sclerosis and amyotrophic lateral sclerosis.
    Foster HD; Hoffer A
    Med Hypotheses; 2004; 62(2):177-81. PubMed ID: 14962622
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum uric acid levels of patients with multiple sclerosis and other neurological diseases.
    Peng F; Zhang B; Zhong X; Li J; Xu G; Hu X; Qiu W; Pei Z
    Mult Scler; 2008 Mar; 14(2):188-96. PubMed ID: 17942520
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potential therapeutic advantages of guanosine over inosine in multiple sclerosis.
    Hanson EA
    Med Hypotheses; 2009 Oct; 73(4):627-8. PubMed ID: 19564082
    [No Abstract]   [Full Text] [Related]  

  • 35. Glatiramer acetate in multiple sclerosis.
    Mezzapesa DM; Rovaris M; Filippi M
    Expert Rev Neurother; 2005 Jul; 5(4):451-8. PubMed ID: 16026228
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reactive species and diabetes: counteracting oxidative stress to improve health.
    Pérez-Matute P; Zulet MA; Martínez JA
    Curr Opin Pharmacol; 2009 Dec; 9(6):771-9. PubMed ID: 19766058
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Uric acid nephrolithiasis: proton titration of an essential molecule?
    Moe OW
    Curr Opin Nephrol Hypertens; 2006 Jul; 15(4):366-73. PubMed ID: 16775450
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Boosting endogenous neuroprotection in multiple sclerosis: the ASsociation of Inosine and Interferon beta in relapsing- remitting Multiple Sclerosis (ASIIMS) trial.
    Gonsette RE; Sindic C; D'hooghe MB; De Deyn PP; Medaer R; Michotte A; Seeldrayers P; Guillaume D;
    Mult Scler; 2010 Apr; 16(4):455-62. PubMed ID: 20200198
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antioxidant status of bilirubin and uric acid in patients with myasthenia gravis.
    Fuhua P; Xuhui D; Zhiyang Z; Ying J; Yu Y; Feng T; Jia L; Lijia G; Xueqiang H
    Neuroimmunomodulation; 2012; 19(1):43-9. PubMed ID: 22067621
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chloric acid(I) affects antioxidant defense of lung epitelial cells.
    Robaszkiewicz A; Pogorzelska M; Bartosz G; Soszyński M
    Toxicol In Vitro; 2011 Oct; 25(7):1328-34. PubMed ID: 21569832
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.